HCPCS Level II C9601: Drug‑Eluting Intracoronary Stent, Additional Branch
Commercial payers pay $1909 on average nationally for this procedure.
HCPCS Level II code C9601 describes percutaneous transcatheter placement of drug-eluting intracoronary stent(s) for an additional branch of a major coronary artery performed in conjunction with coronary angioplasty; service type is a percutaneous coronary stent placement procedure and the typical site of service is a hospital catheterization laboratory or ambulatory surgical center where interventional cardiology procedures are performed.
For related coverage guidance, see recent payer policy updates: Cardiac Computed Tomography (CCT)/Coronary Computed Tomographic Angiography (CCTA), Cardiovascular Disease Risk Assessment, Biomarkers for Myocardial Infarction and Chronic Heart Failure.
Customize your policy alerts
Sign up for hcpcs C9601 policy alerts
Get alerted when payer policies referencing C9601 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
National commercial reimbursement for HCPCS C9601 centers on BUCA’s average commercial rate of $1,908.80, with notable variation across major payers. Blue Cross Blue Shield (BCBS) and UnitedHealth Group show high tops ($8,030.60 and $35,564.00 respectively) and large central tendencies, while Cigna and Aetna present much lower medians ($309.90 and $627.00). BUCA’s mean provides a mid-market anchor between these extremes without min/max bounds. Dispersion analysis (P75 minus P25) highlights concentration and spread: Blue Cross Blue Shield’s dispersion is $3,855.40, UnitedHealth Group’s is $2,460.70, BUCA’s is $2,165.00, Aetna’s is $648.40, and Cigna’s is $0.00. Thus Cigna is the tightest (no interquartile spread) and BCBS the widest, indicating the greatest variability in commercial payments among the listed payers.